These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 21334455)
1. Predicting microRNA modulation in human prostate cancer using a simple String IDentifier (SID1.0). Albertini MC; Olivieri F; Lazzarini R; Pilolli F; Galli F; Spada G; Accorsi A; Rippo MR; Procopio AD J Biomed Inform; 2011 Aug; 44(4):615-20. PubMed ID: 21334455 [TBL] [Abstract][Full Text] [Related]
2. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Murata T; Takayama K; Katayama S; Urano T; Horie-Inoue K; Ikeda K; Takahashi S; Kawazu C; Hasegawa A; Ouchi Y; Homma Y; Hayashizaki Y; Inoue S Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):356-61. PubMed ID: 20820187 [TBL] [Abstract][Full Text] [Related]
3. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Osman A; Fälker K Platelets; 2011; 22(6):433-41. PubMed ID: 21438667 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139 [TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391 [TBL] [Abstract][Full Text] [Related]
6. Widespread deregulation of microRNA expression in human prostate cancer. Ozen M; Creighton CJ; Ozdemir M; Ittmann M Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Ma S; Chan YP; Kwan PS; Lee TK; Yan M; Tang KH; Ling MT; Vielkind JR; Guan XY; Chan KW Cancer Res; 2011 Jan; 71(2):583-92. PubMed ID: 21224345 [TBL] [Abstract][Full Text] [Related]
8. The microRNA profile of prostate carcinoma obtained by deep sequencing. Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999 [TBL] [Abstract][Full Text] [Related]
9. Target identification of microRNAs expressed highly in human embryonic stem cells. Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866 [TBL] [Abstract][Full Text] [Related]
11. Computational identification of novel microRNAs and targets in Brassica napus. Xie FL; Huang SQ; Guo K; Xiang AL; Zhu YY; Nie L; Yang ZM FEBS Lett; 2007 Apr; 581(7):1464-74. PubMed ID: 17367786 [TBL] [Abstract][Full Text] [Related]
12. miRNApath: a database of miRNAs, target genes and metabolic pathways. Chiromatzo AO; Oliveira TY; Pereira G; Costa AY; Montesco CA; Gras DE; Yosetake F; Vilar JB; Cervato M; Prado PR; Cardenas RG; Cerri R; Borges RL; Lemos RN; Alvarenga SM; Perallis VR; Pinheiro DG; Silva IT; Brandão RM; Cunha MA; Giuliatti S; Silva WA Genet Mol Res; 2007 Oct; 6(4):859-65. PubMed ID: 18058708 [TBL] [Abstract][Full Text] [Related]
13. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways. Lichner Z; Ding Q; Samaan S; Saleh C; Nasser A; Al-Haddad S; Samuel JN; Fleshner NE; Stephan C; Jung K; Yousef GM J Pathol; 2015 Oct; 237(2):226-37. PubMed ID: 26011734 [TBL] [Abstract][Full Text] [Related]
14. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664 [TBL] [Abstract][Full Text] [Related]
15. The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers. Porkka KP; Ogg EL; Saramäki OR; Vessella RL; Pukkila H; Lähdesmäki H; van Weerden WM; Wolf M; Kallioniemi OP; Jenster G; Visakorpi T Genes Chromosomes Cancer; 2011 Jul; 50(7):499-509. PubMed ID: 21472816 [TBL] [Abstract][Full Text] [Related]
16. Detection of microRNAs in prostate cancer cells by microRNA array. Tang X; Tang X; Gal J; Kyprianou N; Zhu H; Tang G Methods Mol Biol; 2011; 732():69-88. PubMed ID: 21431706 [TBL] [Abstract][Full Text] [Related]
17. Identification of direct targets for the miR-17-92 cluster by proteomic analysis. Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348 [TBL] [Abstract][Full Text] [Related]
18. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056 [TBL] [Abstract][Full Text] [Related]
19. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene. Yi YH; Sun XS; Qin JM; Zhao QH; Liao WP; Long YS J Neurosci Methods; 2010 Jun; 190(1):34-8. PubMed ID: 20435064 [TBL] [Abstract][Full Text] [Related]
20. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]